AlloVir, Inc.

WHO'M
ai
Digital Profiler. Simply click the AI button
CUSIP

019818103
SEDOL

BL9XBL4
CIK

0001754068

www.allovir.com
LEI:
FIGI: BBG00P80SH34
ALVR

AlloVir, Inc.
GICS: - · Sector: Healthcare · Sub-Sector: Biotechnology
AI
PROFILER
NAME
AlloVir, Inc.
ISIN
US0198181036
TICKER
ALVR
MIC
XNAS
REUTERS
ALVR.OQ
BLOOMBERG
ALVR US
FOR INVESTORS
FOR TRADERS
Securities Trading Warrants

The X-News Explorer is the ultimate source of information for investors with an affinity for the stock market who want to get a quick and convenient overview of the current news situation of a listed company. Various newswire services are available here. If a news alert is displayed, you will find company news that may be of interest to you. This service is provided by PR-Newswire.

Tue, 12.11.2024       AlloVir
US0198181036

NEW YORK, Nov. 12, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

AlloVir, Inc. (NASDAQ: ALVR)'s merger with Kalaris Therapeutics. If you are an AlloVir shareholder, click here to learn more about your rights and options.

Fri, 08.11.2024       AlloVir
US0198181036

NEW YORK, Nov. 8, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

EMCORE Corporation (NASDAQ: EMKR)'s sale to Velocity One for $3.10 per share in cash. If you are an EMCORE shareholder, click here to learn more about your legal rights and options.

We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Information on product placements

 

SMART * AD
EN GIF 970X250

P R O D U C T   S U G G E S T I O N S